...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Maternal and perinatal morbidity and mortality in severe pre-eclampsia and eclampsia in a tertiary care hospital: a prospective study
【24h】

Maternal and perinatal morbidity and mortality in severe pre-eclampsia and eclampsia in a tertiary care hospital: a prospective study

机译:三级护理医院中严重先兆子痫和子痫的母亲和围产儿发病率和死亡率:一项前瞻性研究

获取原文

摘要

Background: Hypertensive disorders of pregnancy are a leading cause of maternal and perinatal morbidity and mortality worldwide. In India, they account for the third most important cause of maternal mortality. The objective of this study was to evaluate maternal and perinatal outcome and complications in cases with severe pre-eclampsia and eclampsia and measures to prevent them. Methods: A prospective study was carried out on 100 patients with severe pre-eclampsia and eclampsia in tertiary care referral hospital over a period of one year i.e. from November 2017 to October 2018. Only those cases with initial blood pressure reading of ≥160/110mmHg or presenting with eclampsia were in included in the study. Detailed history and examination was carried out. Investigations and management were carried out as per standardized department protocol and maternal and fetal outcomes were analyzed. Results: 48% of women were between 21-25 years age, 82% were from rural area, and 86% cases were unbooked, 68% cases were primigravida. Liver Function Tests were deranged in 18% of the patients and 19% had abnormal Renal Function Tests. Labetalol was the most commonly used antihypertensive. Lower segment cesarean section was the mode of delivery in 59% of the cases. Most common maternal complication was Eclampsia. There were 5 maternal deaths i.e. maternal death rate was 5%. 54.3% of live births needed NICU admission and out of these 50% were preterm deliveries. Conclusions: Accessible healthcare and health education and awareness regarding antenatal checkup for all women will lead to early detection of severe pre-eclampsia. Hence, early treatment and management of patient’s complications will certainly improve the maternal and perinatal outcome.
机译:背景:妊娠高血压疾病是全球孕产妇和围产期发病率和死亡率的主要原因。在印度,它们是孕产妇死亡的第三大重要原因。这项研究的目的是评估严重先兆子痫和子痫患者的母体和围产儿结局和并发症以及预防措施。方法:前瞻性研究在2017年11月至2018年10月的一年中,即2017年11月至2018年10月,在三级转诊医院对100例重度先兆子痫和子痫的患者进行了研究。仅那些初次血压读数≥160/ 110mmHg的患者或子痫发作均包括在研究中。详细的病史和检查进行了。根据标准化部门规程进行调查和管理,并分析母婴结局。结果:48%的女性年龄在21-25岁之间,82%的女性来自农村地区,86%的女性未登记,68%的女性为初产妇。 18%的患者进行了肝功能检查,其中19%的肾功能检查异常。拉贝洛尔是最常用的降压药。下段剖宫产是59%病例的分娩方式。产妇最常见的并发症是子痫。有5名孕产妇死亡,即孕产妇死亡率为5%。 54.3%的活产儿需要NICU入院,其中50%为早产。结论:所有妇女均可获得的保健和健康教育以及对产前检查的意识将导致早期发现严重先兆子痫。因此,对患者并发症的早期治疗和处理无疑会改善孕产妇和围产儿的结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号